JOHANNESBURG, Jan 8 (Reuters) - South Africa's rand firmed against the dollar on Friday, recovering ground after a torrid week in which the country recorded a peak in daily COVID-19 infections and doubts over its vaccine supplies came to the fore.
At 1623 GMT, the rand ZAR=D3 was trading at 15.3275 against the U.S. currency, up 0.8% on its previous close.
The rand was partially helped by the dollar .DXY softening after a weak U.S. jobs report though news that South Africa would get an initial batch of vaccines from the Serum Institute of India also comforted investors. the rand was still on track for losses of more than 4% against the greenback this week.
The government has come in for heavy criticism in recent days from scientists, trade unions and health workers over its vaccine strategy. At a time when wealthier nations are already rolling out immunisations, South Africa has yet to receive its first doses and only recently made public its inoculation plans. sluggish vaccination programme would further dent prospects for economic recovery in the continent's most industrialised nation.
Johannesburg-listed stocks advanced for the fifth consecutive day on Friday, reaching record highs, with the All-share index .JALSH closing up 0.76% at 63,519 points and the blue-chip top-40 index .JTOPI 0.72% higher at 58,423 points.
Petrochemicals firm Sasol SOLJ.J was among the gainers, rising 4.56% after oil prices surged. further gains, gold shares .JGLDX fell 3.23% after the bullion price weakened. Government bonds were little changed, with the yield on the 2030 bond ZAR2030= at 8.795%.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.